CYBERMED LIFE - ORGANIC  & NATURAL LIVING

SCIENTIFIC STUDIES & BIOMEDICAL LITERATURE

Analysis of adverse events following immunization in Minas Gerais, Brazil, 2011: a cross-sectional study. 📎

Written by CYBERMED LIFE NEWS
Attachments:
Download this file (Analysis of adverse events following immunization in Minas Gerais, Brazil, 2011- a cross-sectional study..pdf)Analysis of adverse events following immunization in Minas Gerais, Brazil, 2011- a cross-sectional study..pdf[Analysis of adverse events following immunization in Minas Gerais, Brazil, 2011: a cross-sectional study.]1554 kB
facebook Share on Facebook
Abstract Title:

Analysis of adverse events following immunization in Minas Gerais, Brazil, 2011: a cross-sectional study.

Abstract Source:

Epidemiol Serv Saude. 2016 Jan-Mar;25(1):45-54. PMID: 27861677

Abstract Author(s):

Suelem Santos Silva, Valéria Conceição de Oliveira, Helen Cristiny Teodoro Couto Ribeiro, Tamara Gabriela Silva Alves, Ricardo Bezerra Cavalcante, Eliete Albano de Azevedo Guimarães

Article Affiliation:

Suelem Santos Silva

Abstract:

OBJECTIVE: to analyze the main adverse events occurring following immunization in Minas Gerais State, Brazil, in 2011.

METHODS: this is a cross-sectional study using secondary data from the Brazilian Information System on Adverse Events Following Immunization.

RESULTS: 1,449 adverse events were found; more than half occurred in children under one year of age (56.1%; OR=1.39; 95%CI: 1.08;1.78); the highest rates per 100,000 doses administered were found in the Southern Triangle (36.3), Northwest (25.7) and Southern (22.7) areas of the state; tetravalent vaccine had the highest reactogenicity (46.1%) and hypotonic-hyporesponsive episode was the most frequent event (15.9%); events were significantly associated with inactivated vaccines (OR=4.08; 95%CI: 3.51;4.75); most of the reported events were closed as 'undefined' (58.9%).

CONCLUSION: events were found in all regions of Minas Gerais state and were most frequent following administration of inactivated vaccines and among children under one year of age.


Related Articles

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.